Can treatment with the monoclonal antibody BMA031 induce cytokine release?
Zlabinger
G J
GJ
Institute of Immunology, University of Vienna, Austria.
Pohanka
E
E
Stuhlmeier
K M
KM
Eher
R
R
Schmaldienst
S
S
Watschinger
B
B
Steiner
G
G
Kovarik
J
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006084:Graft Rejection; D006801:Humans; D007371:Interferon-gamma / Q000097:blood*; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma